DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Sanchez-Bilbao L, Martinez-Lopez D, Revenga M. et al.
Anti-IL-6 Receptor Tocilizumab in Refractory Gravesʼ Orbitopathy: National Multicenter Observational Study of 48 Patients.
J Clin Med 2020;
9: 2816
doi:10.3390/jcm9092816
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.